nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgements
|
|
|
|
22 |
S3 |
p. iii6 |
artikel |
2 |
Authors index
|
|
|
|
22 |
S3 |
p. iii46-iii48 |
artikel |
3 |
Committees and congress management
|
|
|
|
22 |
S3 |
p. iii5 |
artikel |
4 |
Editorial Board
|
|
|
|
22 |
S3 |
p. ii-iii |
artikel |
5 |
Invited lectures
|
|
|
|
22 |
S3 |
p. iii14-iii21 |
artikel |
6 |
Keynote lectures
|
|
|
|
22 |
S3 |
p. iii13 |
artikel |
7 |
Posters A: Apoptosis
|
|
|
|
22 |
S3 |
p. iii25 |
artikel |
8 |
Posters B: Biomarker development & validation
|
|
|
|
22 |
S3 |
p. iii26-iii28 |
artikel |
9 |
Posters C: Downstream signalling pathways
|
|
|
|
22 |
S3 |
p. iii29-iii30 |
artikel |
10 |
Posters D: Drug profiles - Preclinical
|
|
|
|
22 |
S3 |
p. iii31-iii34 |
artikel |
11 |
Posters E: Immunological targets
|
|
|
|
22 |
S3 |
p. iii35-iii36 |
artikel |
12 |
Posters F: Molecular diagnosis & patient selection
|
|
|
|
22 |
S3 |
p. iii37-iii38 |
artikel |
13 |
Posters G: Phase 1 and other clinical studies
|
|
|
|
22 |
S3 |
p. iii39-iii41 |
artikel |
14 |
Posters H: Target identification & validation
|
|
|
|
22 |
S3 |
p. iii42-iii43 |
artikel |
15 |
Poster titles and authors
|
|
|
|
22 |
S3 |
p. iii10-iii12 |
artikel |
16 |
Proffered papers
|
|
|
|
22 |
S3 |
p. iii22-iii24 |
artikel |
17 |
Program, Monday, March 7
|
|
|
|
22 |
S3 |
p. iii7 |
artikel |
18 |
Program, Tuesday, March 8
|
|
|
|
22 |
S3 |
p. iii8 |
artikel |
19 |
Program, Wednesday, March 9
|
|
|
|
22 |
S3 |
p. iii9 |
artikel |
20 |
Subject index
|
|
|
|
22 |
S3 |
p. iii44-iii45 |
artikel |
21 |
Table of Contents
|
|
|
|
22 |
S3 |
p. iv |
artikel |